摘要:美国食品与药品监督管理局(FDA)批准了Cinqair,用于年龄在18岁及以上的严重哮喘患者的维持治疗。哮喘是一种会导致肺部气道出现炎症的慢性疾病。严重哮喘发作时非常危险,甚至会危及生命,所以通常需要住院治疗。研究者们利用随机化双盲实验对该药物的安全性和有效性进行了调查。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering